Genetic mutations in head and neck cancer: utilizing existing treatments

Pharmacogenomics. 2014;15(12):1553-5. doi: 10.2217/pgs.14.122.
No abstract available

Keywords: clinical trials; exceptional responders; loss-of-function; whole-exome sequencing.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacokinetics
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Biomarkers, Pharmacological
  • Cetuximab
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / genetics*
  • Head and Neck Neoplasms / pathology
  • Humans
  • Mutation
  • Papillomaviridae / genetics
  • Papillomaviridae / pathogenicity

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Pharmacological
  • Cetuximab